Young & Partners Pharma and Biotech M&A Review and Outlook (January 20, 2023)Jonathan Choi2023-01-26T15:10:20+00:00January 20th, 2023|Featured, Our Publications|
Young & Partners Chemical M&A Review and Outlook (January 17, 2023)Jonathan Choi2023-01-26T15:10:48+00:00January 17th, 2023|Featured, Our Publications|
Disruptions to hit M&A, financing (ICIS Chemical Business December 2 – December 8, 2022)Jonathan Choi2023-01-26T15:01:39+00:00December 2nd, 2022|Featured, Our Publications|
Young & Partners 2022 Chemical Conference: Carlos Cabrera, David Roesser: Green Chemicals: Band Aid or a Real Solution?”Jonathan Choi2022-12-30T18:02:28+00:00November 15th, 2022|Our Broadcasts|
Young & Partners 2022 Chemical Conference: Jonathan Woetzel Fireside Chat: China and the U.S.: A Review of the IssuesJonathan Choi2022-12-30T17:27:17+00:00November 15th, 2022|Our Broadcasts|
2022 Chemical Conference Speaker SummaryJonathan Choi2022-12-21T16:36:16+00:00November 15th, 2022|Chemical Conferences|
Young & Partners 2022 Pharmaceutical Executive Summit: Dealing with the Disruptive EnvironmentJonathan Choi2022-12-30T17:15:17+00:00October 26th, 2022|Our Broadcasts|
Young & Partners 2022 Pharmaceutical Executive Summit: Doug Long: The Pharmaceutical Market: Trends, Issues and OutlookJonathan Choi2022-12-30T17:07:51+00:00October 26th, 2022|Our Broadcasts|
Young & Partners 2022 Pharmaceutical Executive Summit: Peter Marks Fireside Chat: Latest Development in Complex Biological ProductsJonathan Choi2022-12-30T17:02:34+00:00October 26th, 2022|Our Broadcasts|
Young & Partners 2022 Pharmaceutical Executive Summit: Peter Marks Keynote Speech: Gene Therapy- Unlocking the PromiseJonathan Choi2022-12-30T17:03:48+00:00October 26th, 2022|Our Broadcasts|
